<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04603170</url>
  </required_header>
  <id_info>
    <org_study_id>13180899</org_study_id>
    <nct_id>NCT04603170</nct_id>
  </id_info>
  <brief_title>Relationships of Executive Functions, Severity of Psychiatric Symptoms With Response to Therapy</brief_title>
  <official_title>University of Bojnord</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Malahat Amani</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bojnord</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was conducted to investigate the moderating role of executive functions in the&#xD;
      relationship between the severity of psychiatric symptoms and response to therapy. The&#xD;
      statistical population of this study was all outpatients with anxiety disorders and&#xD;
      depression who referred to psychiatric clinics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was conducted to investigate the moderating role of executive functions in the&#xD;
      relationship between the severity of psychiatric symptoms and response to drug therapy in&#xD;
      depressed and anxious patients. The statistical population of this study was all outpatients&#xD;
      with anxiety disorders and depression who referred to psychiatric clinics. 164 participants&#xD;
      completed Outcome Questionnaire, Brief Symptom Inventory, and Behavior Rating Inventory of&#xD;
      Executive Function (BRIEF).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">March 1, 2019</completion_date>
  <primary_completion_date type="Actual">February 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Outcome questionnaire</measure>
    <time_frame>ONE WEEK</time_frame>
    <description>This questionnaire was designed to assess response to treatment. This questionnaire has the dimension of mental distress or signs of distress, interpersonal relationships, and social role. This 45-item questionnaire is answered on a 5-point Likert scale ranging 0 to 4 (not at all to extremely).Scores range from 0 to180. higher scores mean a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brief Symptom Inventory</measure>
    <time_frame>ONE WEEK</time_frame>
    <description>This inventory measures the symptoms of psycho-somatization, obsessive-compulsive, interpersonal sensitivity, paranoid thoughts, depression, psychosis, general anxiety, hostility and anxiety. It was answered to questions based on the 5-point Likert scale ranging from 0 to 4 (not at all to perfectly). This questionnaire is 53 items. Scores range from 0 to 212.range of score are higher scores mean a worse outcome and mental health problems.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Behavior Rating Inventory of Executive Function</measure>
    <time_frame>ONE WEEK</time_frame>
    <description>This questionnaire is used to measure the executive functions of adults aged 18 to 90 from their daily performance in the natural environment. It has 75 items that measure factors including response inhibition, shifting, emotional control, self-monitoring, initiation, working memory, planning, material organization, and task monitoring. It was answered to questions based on the 3-point Likert scale ranging from 0 to 2 (not at all to extremely). the scores range 0 to 150. High score is indicator of weak executive functions.</description>
  </primary_outcome>
  <enrollment type="Actual">164</enrollment>
  <condition>Patient Acceptance of Health Care</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>DRUG</intervention_name>
    <description>taking drug medication prescribed by psychiatrists for at least one month</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The statistical population included all adult outpatients with anxiety and depression&#xD;
        disorders who referred to psychiatric offices in Bojnord city Sample was selected among the&#xD;
        clients of psychiatric offices who received the diagnosis of anxiety and depression&#xD;
        disorders and volunteer to participate in the study were sample (n=164)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        receiving a diagnosis of anxiety and depression disorders, age over 18 years, and taking&#xD;
        drug medication prescribed by psychiatrists for at least one month.-&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  having psychotic disorders, age under 18 years and absence from treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Malahat amani, ph.d</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bojnord</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Malahat Amani</name>
      <address>
        <city>Bojnourd</city>
        <state>North Khorsan</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 20, 2020</study_first_submitted>
  <study_first_submitted_qc>October 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2020</study_first_posted>
  <last_update_submitted>October 26, 2020</last_update_submitted>
  <last_update_submitted_qc>October 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Bojnord</investigator_affiliation>
    <investigator_full_name>Malahat Amani</investigator_full_name>
    <investigator_title>Malahat Amani</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

